Language selection


Biomanufacturing: Advancing life sciences industry in Canada

From: Innovation, Science and Economic Development Canada

Biomanufacturing in Canada

Ensuring access to critical vaccines, therapeutics and other health products is a priority for the Government of Canada. At the outset of the COVID-19 pandemic, the Government of Canada took early and decisive action to strengthen Canada's biomanufacturing capacity to protect Canadians. We continue to invest in domestic biomanufacturing capabilities and secure medical countermeasures.

Biomanufacturing and Life Sciences Strategy

Explore the 5-pillar strategy to strengthen the biomanufacturing and life sciences sector

Biomanufacturing series: Medicago

Learn about Canada’s first plant-based manufacturing facility to both develop and manufacture vaccines and therapeutics

Biomanufacturing ecosystem
Find out why domestic biomanufacturing is important for Canada
Biomanufacturing infrastructure
Learn more about the Biologics Manufacturing Centre
Biomanufacturing projects underway
Find out about current biomanufacturing projects in Canada

Advancing the life sciences industry

Since March 2020, the government has taken a multifaceted approach including over $1 billion in advance purchase agreements to secure a domestic supply of up to 429 million doses of promising COVID-19 vaccines. The Government of Canada has also committed $792 million through the Strategic Innovation Fund (SIF), to support research and development, clinical trials, and the manufacturing of vaccines and therapeutic drugs to fight COVID-19.

Innovation, Science, and Economic Development Canada – in partnership with Health Canada, the Public Health Agency of Canada, and partner departments and agencies – is actively engaging with stakeholders. This engagement is to explore ways that the Government of Canada can support future pandemic preparedness, including through vaccine and therapeutic manufacturing in Canada.

What We Heard Report
Results of the consultation on biomanufacturing capacity in Canada

Biomanufacturing gallery
Browse through a selection of biomanufacturing related videos and articles

COVID-19 health product industry
Information for health product manufacturers and distributors in relation to COVID-19

Related links:


General inquiries

Do you have questions? Contact us

Media Relations

Innovation, Science and Economic Development Canada
Telephone: 343-291-1777

Did you find what you were looking for?

What was wrong?

You will not receive a reply. Telephone numbers and email addresses will be removed.
Maximum 300 characters

Thank you for your feedback

Date modified: